The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway Rats

Background: Nasal obstruction is considered the most serious problem for patients with allergic rhinitis. We have previously established a model of nasal obstruction in guinea pigs. In the present study, we tried to establish an allergic model of nasal obstruction using Brown Norway (BN) rats to eva...

Full description

Bibliographic Details
Main Authors: Hirokazu Kawasaki, Toshihiko Kaise, Haruhiko Manabe, Akihiko Watanabe
Format: Article
Language:English
Published: Elsevier 2005-01-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015310558
_version_ 1818505271910072320
author Hirokazu Kawasaki
Toshihiko Kaise
Haruhiko Manabe
Akihiko Watanabe
author_facet Hirokazu Kawasaki
Toshihiko Kaise
Haruhiko Manabe
Akihiko Watanabe
author_sort Hirokazu Kawasaki
collection DOAJ
description Background: Nasal obstruction is considered the most serious problem for patients with allergic rhinitis. We have previously established a model of nasal obstruction in guinea pigs. In the present study, we tried to establish an allergic model of nasal obstruction using Brown Norway (BN) rats to evaluate the effects of phosphodiesterase (PDE) 4 inhibitors in this model. Methods: The volume of the nasal cavity was measured with an acoustic rhinometer. Decrease in the volume of the nasal cavity was taken as nasal obstruction. BN rats were actively sensitized with ovalbumin conjugated with aluminium hydroxide. Intranasal antigen instillation induced biphasic nasal obstruction in sensitized BN rats. Results: Early and late phase responses (EPR and LPR) were observed peaking at 0.5 and 6 hours after the antigen challenge, respectively. Chlorpheniramine did not inhibit EPR or LPR at 10 mg/kg, although the dose was sufficient for the compound to exert its anti-histamine activity. Prednisolone inhibited both responses at 30 mg/kg. Rolipram and CDP-840, PDE4 inhibitors, inhibited both responses at 100 mg/kg. KF19514, a PDE1/4 dual inhibitor, inhibited EPR at 0.1 mg/kg or more and inhibited LPR at 10 mg/kg. Conclusions: The present study provides a simple model of allergic biphasic nasal obstruction in BN rats, and also suggests that the PDE4 inhibitor may alleviate nasal obstruction in patients with allergic rhinitis.
first_indexed 2024-12-10T21:48:26Z
format Article
id doaj.art-60bcdb38c8a4460191608633e2d29b81
institution Directory Open Access Journal
issn 1323-8930
language English
last_indexed 2024-12-10T21:48:26Z
publishDate 2005-01-01
publisher Elsevier
record_format Article
series Allergology International
spelling doaj.art-60bcdb38c8a4460191608633e2d29b812022-12-22T01:32:18ZengElsevierAllergology International1323-89302005-01-0154342743310.2332/allergolint.54.427The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway RatsHirokazu Kawasaki0Toshihiko Kaise1Haruhiko Manabe2Akihiko Watanabe3Department of Allergy Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.Department of Allergy Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.Department of Allergy Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.Department of Allergy Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.Background: Nasal obstruction is considered the most serious problem for patients with allergic rhinitis. We have previously established a model of nasal obstruction in guinea pigs. In the present study, we tried to establish an allergic model of nasal obstruction using Brown Norway (BN) rats to evaluate the effects of phosphodiesterase (PDE) 4 inhibitors in this model. Methods: The volume of the nasal cavity was measured with an acoustic rhinometer. Decrease in the volume of the nasal cavity was taken as nasal obstruction. BN rats were actively sensitized with ovalbumin conjugated with aluminium hydroxide. Intranasal antigen instillation induced biphasic nasal obstruction in sensitized BN rats. Results: Early and late phase responses (EPR and LPR) were observed peaking at 0.5 and 6 hours after the antigen challenge, respectively. Chlorpheniramine did not inhibit EPR or LPR at 10 mg/kg, although the dose was sufficient for the compound to exert its anti-histamine activity. Prednisolone inhibited both responses at 30 mg/kg. Rolipram and CDP-840, PDE4 inhibitors, inhibited both responses at 100 mg/kg. KF19514, a PDE1/4 dual inhibitor, inhibited EPR at 0.1 mg/kg or more and inhibited LPR at 10 mg/kg. Conclusions: The present study provides a simple model of allergic biphasic nasal obstruction in BN rats, and also suggests that the PDE4 inhibitor may alleviate nasal obstruction in patients with allergic rhinitis.http://www.sciencedirect.com/science/article/pii/S1323893015310558acoustic rhinometryallergic rhinitisBN ratnasal obstructionPDE inhibitor
spellingShingle Hirokazu Kawasaki
Toshihiko Kaise
Haruhiko Manabe
Akihiko Watanabe
The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway Rats
Allergology International
acoustic rhinometry
allergic rhinitis
BN rat
nasal obstruction
PDE inhibitor
title The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway Rats
title_full The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway Rats
title_fullStr The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway Rats
title_full_unstemmed The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway Rats
title_short The Phosphodiesterase 4 Inhibitor Prevents Antigen-induced Biphasic Nasal Obstruction in Brown Norway Rats
title_sort phosphodiesterase 4 inhibitor prevents antigen induced biphasic nasal obstruction in brown norway rats
topic acoustic rhinometry
allergic rhinitis
BN rat
nasal obstruction
PDE inhibitor
url http://www.sciencedirect.com/science/article/pii/S1323893015310558
work_keys_str_mv AT hirokazukawasaki thephosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats
AT toshihikokaise thephosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats
AT haruhikomanabe thephosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats
AT akihikowatanabe thephosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats
AT hirokazukawasaki phosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats
AT toshihikokaise phosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats
AT haruhikomanabe phosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats
AT akihikowatanabe phosphodiesterase4inhibitorpreventsantigeninducedbiphasicnasalobstructioninbrownnorwayrats